Balance Sheet

Cash Flow Statement

Amortization Amortization Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Change in Working Capital Change in Working Capital Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Legend Biotech (LEGN) Change in Intangibles (2020 - 2023)

Legend Biotech filings provide 4 years of Change in Intangibles readings, the most recent being -$96000.0 for Q3 2023.

On a quarterly basis, Change in Intangibles fell 110.51% to -$96000.0 in Q3 2023 year-over-year; TTM through Sep 2024 was -$96000.0, a 93.52% increase, with the full-year FY2022 number at -$1.3 million, up 57.97% from a year prior.
Change in Intangibles hit -$96000.0 in Q3 2023 for Legend Biotech, up from -$348000.0 in the prior quarter.
In the past five years, Change in Intangibles ranged from a high of $913000.0 in Q3 2022 to a low of -$4.0 million in Q4 2020.
Median Change in Intangibles over the past 4 years was -$654000.0 (2021), compared with a mean of -$987076.9.
Biggest five-year swings in Change in Intangibles: crashed 528.33% in 2021 and later skyrocketed 180.73% in 2022.
Legend Biotech's Change in Intangibles stood at -$4.0 million in 2020, then rose by 20.4% to -$3.2 million in 2021, then soared by 57.97% to -$1.3 million in 2022, then skyrocketed by 92.88% to -$96000.0 in 2023.
The last three reported values for Change in Intangibles were -$96000.0 (Q3 2023), -$348000.0 (Q2 2023), and $310000.0 (Q1 2023) per Business Quant data.